Literature DB >> 11156412

Truncation of the extracellular region abrogrates cell contact but retains the growth-suppressive activity of E-cadherin.

C Y Sasaki1, H Lin, P J Morin, D L Longo.   

Abstract

E-cadherin has been demonstrated to induce growth suppression and decrease the invasiveness of cancer cells and thus has been proposed to be a tumor suppressor gene. The ability of E-cadherin to mediate cell-cell contact and contact inhibition presumably accounts for its antitumor effects, which are attributed to the extracellular domain of the protein. Here we report that blocking the ability of E-cadherin to mediate contact inhibition by either antagonistic antibodies or expression of a mutant form of E-cadherin with the extracellular region deleted does not abrogate growth suppression. Transfection of the E-cadherin gene into the human prostate cancer cell line TSU.Pr-1 induced cell-cell contact formation, growth suppression, and redistribution of beta-catenin to the cell membrane. Treatment of the E-cadherin transfectant (CAD) with blocking antibodies disrupted cell-cell contact formation but did not influence the growth rate, suggesting that cell-cell interaction is not required for E-cadherin-mediated growth suppression. Similarly, transfection of an E-cadherin construct in which the NH2-terminal (extracellular) region was deleted did not allow cell-cell contact formation but induced growth suppression. In contrast, transfection of an E-cadherin construct in which the COOH-terminal (cytoplasmic) region was deleted did not induce suppression but promoted cell contact formation. In cells expressing E-cadherin lacking the cytoplasmic region, beta-catenin was evenly distributed in the cytoplasm. By contrast, in cells expressing E-cadherin lacking the extracellular region, beta-catenin was cell membrane associated. Growth suppression was always associated with the localization of beta-catenin to the cell membrane. The redistribution of beta-catenin from the cytoplasm to the cell membrane initially suggested the involvement of the Wnt signaling pathway in regulating cell growth. However, only small differences in beta-catenin/T-cell factor signaling were detected in control and E-cadherin-expressing cells, suggesting that the Wnt pathway is not involved. Taken together, these findings suggest that E-cadherin-induced growth inhibition may not be solely attributed to contact inhibition but may involve the redistribution of beta-catenin from the cytoplasm to the cell membrane, and this redistribution may affect growth pathways independent of T-cell factor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11156412

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Cadherins and Pak1 control contact inhibition of proliferation by Pak1-betaPIX-GIT complex-dependent regulation of cell-matrix signaling.

Authors:  Fengming Liu; Liwei Jia; Ann-Marie Thompson-Baine; Jason M Puglise; Martin B A Ter Beest; Mirjam M P Zegers
Journal:  Mol Cell Biol       Date:  2010-02-12       Impact factor: 4.272

2.  Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC).

Authors:  Winifred Lo; Bin Zhu; Arvind Sabesan; Ho-Hsiang Wu; Astin Powers; Rebecca A Sorber; Sarangan Ravichandran; Ina Chen; Lucas A McDuffie; Humair S Quadri; Joal D Beane; Kathleen Calzone; Markku M Miettinen; Stephen M Hewitt; Christopher Koh; Theo Heller; Sholom Wacholder; Udo Rudloff
Journal:  J Med Genet       Date:  2019-02-11       Impact factor: 6.318

3.  Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants.

Authors:  Kristy Lee; Kate Krempely; Maegan E Roberts; Michael J Anderson; Fatima Carneiro; Elizabeth Chao; Katherine Dixon; Joana Figueiredo; Rajarshi Ghosh; David Huntsman; Pardeep Kaurah; Chimene Kesserwan; Tyler Landrith; Shuwei Li; Arjen R Mensenkamp; Carla Oliveira; Carolina Pardo; Tina Pesaran; Matthew Richardson; Thomas P Slavin; Amanda B Spurdle; Mackenzie Trapp; Leora Witkowski; Charles S Yi; Liying Zhang; Sharon E Plon; Kasmintan A Schrader; Rachid Karam
Journal:  Hum Mutat       Date:  2018-11       Impact factor: 4.878

4.  E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases.

Authors:  Xiaolan Qian; Tatiana Karpova; Allan M Sheppard; James McNally; Douglas R Lowy
Journal:  EMBO J       Date:  2004-04-01       Impact factor: 11.598

5.  Oncogenic K-Ras regulates proliferation and cell junctions in lung epithelial cells through induction of cyclooxygenase-2 and activation of metalloproteinase-9.

Authors:  Xue-Qing Wang; Howard Li; Vicki Van Putten; Robert A Winn; Lynn E Heasley; Raphael A Nemenoff
Journal:  Mol Biol Cell       Date:  2008-11-26       Impact factor: 4.138

6.  Regulation of nonsense-mediated mRNA decay: implications for physiology and disease.

Authors:  Rachid Karam; Jordan Wengrod; Lawrence B Gardner; Miles F Wilkinson
Journal:  Biochim Biophys Acta       Date:  2013-03-13

7.  T-cadherin-mediated cell growth regulation involves G2 phase arrest and requires p21(CIP1/WAF1) expression.

Authors:  Zhi-yong Huang; YanLi Wu; Nicolé Hedrick; David H Gutmann
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

8.  Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells.

Authors:  M Comamala; M Pinard; C Thériault; I Matte; A Albert; M Boivin; J Beaudin; A Piché; C Rancourt
Journal:  Br J Cancer       Date:  2011-02-15       Impact factor: 7.640

9.  Overexpression of CD157 contributes to epithelial ovarian cancer progression by promoting mesenchymal differentiation.

Authors:  Simona Morone; Nicola Lo-Buono; Rossella Parrotta; Alice Giacomino; Giulia Nacci; Alfredo Brusco; Alexey Larionov; Paola Ostano; Maurizia Mello-Grand; Giovanna Chiorino; Erika Ortolan; Ada Funaro
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

10.  Functional characterization of E- and P-cadherin in invasive breast cancer cells.

Authors:  David Sarrió; José Palacios; Marta Hergueta-Redondo; Gonzalo Gómez-López; Amparo Cano; Gema Moreno-Bueno
Journal:  BMC Cancer       Date:  2009-03-03       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.